Skip to main content

Ethanol-Making Microbe Tied to Nonalcoholic Fatty Liver Disease

A study adds to evidence linking gut bacteria to liver conditions in people who don’t drink excessive amounts of alcohol. 

Written byNatalia Mesa, PhD
| 4 min read
Illustration of liver with veins in blue and arteries in red
Register for free to listen to this article
Listen with Speechify
0:00
4:00

As its name suggests, nonalcoholic fatty liver disease describes a liver condition in which fat builds up in the livers of people who drink little or no alcohol. It can affect young, healthy people with no other comorbidities, leaving scientists and doctors stumped as to why some livers gradually fail.

A study published in Nature Medicine last week (October 10) provides clues as to a potential cause: the bacteria dwelling in our guts.

As they digest food, these microbes secrete byproducts, many of which are helpful. But some bacteria produce ethanol as they break down sugars, and a previous study in humans and mice linked ethanol-producing bacteria—namely Klebsiella pneumoniae—and fatty liver disease. In some patients, it appears, the commensal relationship between bacteria and host goes sour. The new study goes further, providing a potential mechanism for how ethanol-producing bacteria in the gut can evade diagnostic testing, stealthily dumping ethanol into ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays